Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes

BACKGROUND: (18)F-FDG brain PET measures metabolic changes in neurodegenerative disorders and may discriminate between different diseases even at an early stage. The objective of this study was to classify patients with amyotrophic lateral sclerosis (ALS) and Parkinson plus syndromes (PP). To this e...

Descripción completa

Detalles Bibliográficos
Autores principales: Devrome, Martijn, Van Weehaeghe, Donatienne, De Vocht, Joke, Van Damme, Philip, Van Laere, Koen, Koole, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292827/
https://www.ncbi.nlm.nih.gov/pubmed/30547248
http://dx.doi.org/10.1186/s13550-018-0458-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292827/
https://www.ncbi.nlm.nih.gov/pubmed/30547248
http://dx.doi.org/10.1186/s13550-018-0458-5

Ejemplares similares